Hoshi Y, Uchida Y, Tachikawa M, Ohtsuki S, Couraud P, Suzuki T, et al. Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood-brain barrier. J Cereb Blood Flow Metab. 2020;40:420-436 pubmed publisher

Gertler T, Thompson C, Vanoye C, Millichap J, George A. Functional consequences of a KCNT1 variant associated with status dystonicus and early-onset infantile encephalopathy. Ann Clin Transl Neurol. 2019;6:1606-1615 pubmed publisher

Dong A, Ahemad N, Pan Y, Palanisamy U, Yiap B, Ong C. Functional and structural characterisation of common cytochrome P450 2D6 allelic variants-roles of Pro34 and Thr107 in catalysis and inhibition. Naunyn Schmiedebergs Arch Pharmacol. 2019;: pubmed publisher

Moraes C, Witt G, Kuzikov M, Ellinger B, Calogeropoulou T, Prousis K, et al. Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform. SLAS Discov. 2019;24:346-361 pubmed publisher

Sonawane V, Siddique M, Gatchie L, Williams I, Bharate S, Jayaprakash V, et al. CYP enzymes, expressed within live human suspension cells, are superior to widely-used microsomal enzymes in identifying potent CYP1A1/CYP1B1 inhibitors: Identification of quinazolinones as CYP1A1/CYP1B1 inhibitors that efficiently reverse B[a]P toxi. Eur J Pharm Sci. 2019;131:177-194 pubmed publisher

Madry C, Kyrargyri V, Arancibia Carcamo I, Jolivet R, Kohsaka S, Bryan R, et al. Microglial Ramification, Surveillance, and Interleukin-1? Release Are Regulated by the Two-Pore Domain K+ Channel THIK-1. Neuron. 2018;97:299-312.e6 pubmed publisher

Jans D, Callewaert G, Krylychkina O, Hoffman L, Gullo F, Prodanov D, et al. Action potential-based MEA platform for in vitro screening of drug-induced cardiotoxicity using human iPSCs and rat neonatal myocytes. J Pharmacol Toxicol Methods. 2017;87:48-52 pubmed publisher

Romand S, Spaggiari D, Marsousi N, Samer C, Desmeules J, Daali Y, et al. Characterization of oxycodone in vitro metabolism by human cytochromes P450 and UDP-glucuronosyltransferases. J Pharm Biomed Anal. 2017;144:129-137 pubmed publisher

Spaggiari D, Daali Y, Rudaz S. An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposure. Toxicol Appl Pharmacol. 2016;302:41-51 pubmed publisher

Thiollier T, Wu C, Contamin H, Li Q, Zhang J, Bezard E. Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease. Synapse. 2016;70:231-9 pubmed publisher

Yi J, Kim Y, Lee Y, Bang O, Kim N. Effect of an ethanol extract of Descurainia sophia seeds on Phase I and II drug metabolizing enzymes and P-glycoprotein activity in vitro. BMC Complement Altern Med. 2015;15:441 pubmed publisher

Ahmmed S, Mukherjee P, Bahadur S, Kar A, Mukherjee K, Karmakar S, et al. Interaction potential of Trigonella foenum graceum through cytochrome P450 mediated inhibition. Indian J Pharmacol. 2015;47:530-4 pubmed publisher

Stas J, Bocksteins E, Labro A, Snyders D. Modulation of Closed-State Inactivation in Kv2.1/Kv6.4 Heterotetramers as Mechanism for 4-AP Induced Potentiation. PLoS ONE. 2015;10:e0141349 pubmed publisher

Rapacz A, Sapa J, Pytka K, Dudek M, Filipek B, Szkaradek N, et al. Antiarrhythmic activity of new 2-methoxyphenylpiperazine xanthone derivatives after ischemia/reperfusion in rats. Pharmacol Rep. 2015;67:1163-7 pubmed publisher

Zilbermintz L, Leonardi W, Jeong S, Sjodt M, McComb R, Ho C, et al. Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting. Sci Rep. 2015;5:13476 pubmed publisher

Lucas S, Armstrong D. Protein phosphatase modulation of somatostatin receptor signaling in the mouse hippocampus. Neuropharmacology. 2015;99:232-41 pubmed publisher

Doki K, Sekiguchi Y, Kuga K, Aonuma K, Homma M. Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity. Drug Metab Pharmacokinet. 2015;30:257-62 pubmed publisher

Feng R, Shou J, Zhao Z, He C, Ma C, Huang M, et al. Transforming berberine into its intestine-absorbable form by the gut microbiota. Sci Rep. 2015;5:12155 pubmed publisher

Goldman J, Leeder J, van Haandel L, Pearce R. In Vitro Hepatic Oxidative Biotransformation of Trimethoprim. Drug Metab Dispos. 2015;43:1372-80 pubmed publisher

Bergström G, Christoffersson J, Schwanke K, Zweigerdt R, Mandenius C. Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging. Lab Chip. 2015;15:3242-9 pubmed publisher

Kong D, Li Q, Zhang P, Zhang W, Zhen Y, Ren L. The truth about the lower plasma concentration of the (-)-isomer after racemic doxazosin administration in rats: Stereoselective inhibition of the (-)-isomer by the (+)-isomer at CYP3A. Eur J Pharm Sci. 2015;77:238-45 pubmed publisher

Sasahara K, Shimokawa Y, Hirao Y, Koyama N, Kitano K, Shibata M, et al. Pharmacokinetics and Metabolism of Delamanid, a Novel Anti-Tuberculosis Drug, in Animals and Humans: Importance of Albumin Metabolism In Vivo. Drug Metab Dispos. 2015;43:1267-76 pubmed publisher

Holm N, Nielsen L, Linnet K. CYP3A4 Mediates Oxidative Metabolism of the Synthetic Cannabinoid AKB-48. AAPS J. 2015;17:1237-45 pubmed publisher

Cui H, Hense B, Müller J, Schröder P. Short term uptake and transport process for metformin in roots of Phragmites australis and Typha latifolia. Chemosphere. 2015;134:307-12 pubmed publisher

Sadiq M, Uchida Y, Hoshi Y, Tachikawa M, Terasaki T, Hammarlund Udenaes M. Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport. PLoS ONE. 2015;10:e0118638 pubmed publisher

Decloedt A, Schwarzwald C, De Clercq D, van der Vekens N, Pardon B, Reef V, et al. Risk factors for recurrence of atrial fibrillation in horses after cardioversion to sinus rhythm. J Vet Intern Med. 2015;29:946-53 pubmed publisher

Iwasaki M, Koyanagi S, Suzuki N, Katamune C, Matsunaga N, Watanabe N, et al. Circadian modulation in the intestinal absorption of P-glycoprotein substrates in monkeys. Mol Pharmacol. 2015;88:29-37 pubmed publisher

Adedeji O, Bolaji O, Falade C, Osonuga O, Ademowo O. Validation and pharmacokinetic application of a high-performance liquid chromatographic technique for determining the concentrations of amodiaquine and its metabolite in plasma of patients treated with oral fixed-dose amodiaquine-artesunate combinati. Antimicrob Agents Chemother. 2015;59:5114-22 pubmed publisher

Xie S, Jia Y, Liu A, Dai R, Huang L. Hypaconitine-induced QT prolongation mediated through inhibition of KCNH2 (hERG) potassium channels in conscious dogs. J Ethnopharmacol. 2015;166:375-9 pubmed publisher

Shi H, Jia Y, Peng S, Liao X, Ding L, Liu Y. Metabolic study of Angelica dahurica extracts using a reusable liver microsomal nanobioreactor by liquid chromatography-mass spectrometry. Biomed Chromatogr. 2015;29:1514-1521 pubmed publisher

Uehara S, Uno Y, Inoue T, Murayama N, Shimizu M, Sasaki E, et al. Activation and deactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by cytochrome P450 enzymes and flavin-containing monooxygenases in common marmosets (Callithrix jacchus). Drug Metab Dispos. 2015;43:735-42 pubmed publisher

Sanoh S, Naritomi Y, Fujimoto M, Sato K, Kawamura A, Horiguchi A, et al. Predictability of plasma concentration-time curves in humans using single-species allometric scaling of chimeric mice with humanized liver. Xenobiotica. 2015;45:605-14 pubmed publisher

Zhang C, Zhang J, Huang Y, Liu Z. Macromolecular crowding-assisted fabrication of liquid-crystalline imprinted polymers. Anal Bioanal Chem. 2015;407:2923-31 pubmed publisher

Shimizu M, Hashiguchi M, Shiga T, Nakamura K, Tamura H, Mochizuki M. Quantitation of pilsicainide in microscale samples of human biological fluids using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;985:172-9 pubmed publisher

Astarita G, Avanesian A, Grimaldi B, Realini N, Justinova Z, Panlilio L, et al. Methamphetamine accelerates cellular senescence through stimulation of de novo ceramide biosynthesis. PLoS ONE. 2015;10:e0116961 pubmed publisher

Zhao Y, Hellum B, Liang A, Nilsen O. Inhibitory Mechanisms of Human CYPs by Three Alkaloids Isolated from Traditional Chinese Herbs. Phytother Res. 2015;29:825-34 pubmed publisher

Mosure K, Knipe J, Browning M, Arora V, Shu Y, Phillip T, et al. Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor. J Pharm Sci. 2015;104:2813-23 pubmed publisher

Kazmi F, Barbara J, Yerino P, Parkinson A. A long-standing mystery solved: the formation of 3-hydroxydesloratadine is catalyzed by CYP2C8 but prior glucuronidation of desloratadine by UDP-glucuronosyltransferase 2B10 is an obligatory requirement. Drug Metab Dispos. 2015;43:523-33 pubmed publisher

Barth T, Habenschus M, Lima Moreira F, Ferreira L, Lopes N, Moraes de Oliveira A. In vitro metabolism of the lignan (-)-grandisin, an anticancer drug candidate, by human liver microsomes. Drug Test Anal. 2015;7:780-6 pubmed publisher

Yano K, Mita S, Morimoto K, Haraguchi T, Arakawa H, Yoshida M, et al. Multiple Linear Regression Analysis Indicates Association of P-Glycoprotein Substrate or Inhibitor Character with Bitterness Intensity, Measured with a Sensor. J Pharm Sci. 2015;104:2789-94 pubmed publisher

Stott L, Schnell S, Hogstrand C, Owen S, Bury N. A primary fish gill cell culture model to assess pharmaceutical uptake and efflux: evidence for passive and facilitated transport. Aquat Toxicol. 2015;159:127-37 pubmed publisher

Fan P, Song Y, Berezhkovskiy L, Cheong J, Plise E, Khojasteh S. Practical permeability-based hepatic clearance classification system (HepCCS) in drug discovery. Future Med Chem. 2014;6:1995-2012 pubmed publisher

Gartzke D, Delzer J, Laplanche L, Uchida Y, Hoshi Y, Tachikawa M, et al. Genomic Knockout of Endogenous Canine P-Glycoprotein in Wild-Type, Human P-Glycoprotein and Human BCRP Transfected MDCKII Cell Lines by Zinc Finger Nucleases. Pharm Res. 2015;32:2060-71 pubmed publisher

Rankovic Z. CNS drug design: balancing physicochemical properties for optimal brain exposure. J Med Chem. 2015;58:2584-608 pubmed publisher

Guo W, Shi X, Wang W, Zhang W, Li J. Identification of the rat liver cytochrome P450 enzymes involved in the metabolism of the calcium channel blocker dipfluzine hydrochloride. Environ Toxicol Pharmacol. 2014;38:901-12 pubmed publisher

Wang W, Ni Y, Wang L, Che X, Liu W, Meng Q. Stereoselective oxidation metabolism of 20(S)-protopanaxatriol in human liver microsomes and in rats. Xenobiotica. 2015;45:385-95 pubmed publisher

Bi Y, Zhuang X, Zhu H, Song F, Liu Z, Liu S. Studies on metabolites and metabolic pathways of bulleyaconitine A in rat liver microsomes using LC-MS(n) combined with specific inhibitors. Biomed Chromatogr. 2015;29:1027-34 pubmed publisher

Ru Q, Tian X, Pi M, Chen L, Yue K, Xiong Q, et al. Voltage‑gated K+ channel blocker quinidine inhibits proliferation and induces apoptosis by regulating expression of microRNAs in human glioma U87‑MG cells. Int J Oncol. 2015;46:833-40 pubmed publisher

Hong L, Xu C, O Neal S, Bi H, Huang M, Zheng W, et al. Roles of P-glycoprotein and multidrug resistance protein in transporting para-aminosalicylic acid and its N-acetylated metabolite in mice brain. Acta Pharmacol Sin. 2014;35:1577-85 pubmed publisher

Shinde D, Kim M, Jeong E, Kim Y, Lee J, Shin J, et al. Enantioselective N-demethylation and hydroxylation of sibutramine in human liver microsomes and recombinant cytochrome p-450 isoforms. J Toxicol Environ Health A. 2014;77:1419-30 pubmed publisher

Marois I, Cloutier A, Meunier I, Weingartl H, Cantin A, Richter M. Inhibition of influenza virus replication by targeting broad host cell pathways. PLoS ONE. 2014;9:e110631 pubmed publisher

Yu N, Jiang J, Yu Y, Li H, Huang X, Ma Y, et al. SLC41A1 knockdown inhibits angiotensin II-induced cardiac fibrosis by preventing Mg(2+) efflux and Ca(2+) signaling in cardiac fibroblasts. Arch Biochem Biophys. 2014;564:74-82 pubmed publisher

Wu J, Shaw J, Dubaisi S, Valeriote F, Li J. In vitro metabolism and drug-drug interaction potential of UTL-5g, a novel chemo- and radioprotective agent. Drug Metab Dispos. 2014;42:2058-67 pubmed publisher

Tam T, Liu R, Saleem A, Arnason J, Krantis A, Foster B. Cytochrome P450 3A4 and 2D6-mediated metabolism of leisure and medicinal teas. J Pharm Pharm Sci. 2014;17:294-301 pubmed

Thelingwani R, Bonn B, Chibale K, Masimirembwa C. Physicochemical and drug metabolism characterization of a series of 4-aminoquinoline-3-hydroxypyridin-4-one hybrid molecules with antimalarial activity. Expert Opin Drug Metab Toxicol. 2014;10:1313-24 pubmed publisher

Wang Y, Jiang Y, Wang Y, Kang J, Yu T, Zhao H, et al. Inhibiton of cytochrome P450 isoenzymes and P-gp activity by multiple extracts of Huang-Lian-Jie-Du decoction. J Ethnopharmacol. 2014;156:175-81 pubmed publisher

Tse S, Leung L, Raje S, Seymour M, Shishikura Y, Obach R. Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry. Drug Metab Dispos. 2014;42:2023-32 pubmed publisher

Anwar Mohamed A, Barakat K, Bhat R, Noskov S, Tyrrell D, Tuszynski J, et al. A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity. Toxicol Lett. 2014;230:382-92 pubmed publisher

De Vrieze M, Verzele D, Szucs R, Sandra P, Lynen F. Evaluation of sphingomyelin, cholester, and phosphatidylcholine-based immobilized artificial membrane liquid chromatography to predict drug penetration across the blood-brain barrier. Anal Bioanal Chem. 2014;406:6179-88 pubmed publisher

Yamamiya I, Yoshisue K, Ishii Y, Yamada H, Yoshida K. Species variation in the enantioselective metabolism of tegafur to 5-fluorouracil among rats, dogs and monkeys. J Pharm Pharmacol. 2014;66:1686-97 pubmed publisher

Dinger J, Meyer M, Maurer H. Development of an in vitro cytochrome P450 cocktail inhibition assay for assessing the inhibition risk of drugs of abuse. Toxicol Lett. 2014;230:28-35 pubmed publisher

Massarotti A, Aprile S, Mercalli V, Del Grosso E, Grosa G, Sorba G, et al. Are 1,4- and 1,5-disubstituted 1,2,3-triazoles good pharmacophoric groups?. ChemMedChem. 2014;9:2497-508 pubmed publisher

Nirogi R, Palacharla R, Uthukam V, Manoharan A, Srikakolapu S, Kalaikadhiban I, et al. Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays. Xenobiotica. 2015;45:95-106 pubmed publisher

Vivares A, Sallé Lefort S, Arabeyre Fabre C, Ngo R, Penarier G, Bremond M, et al. Morphological behaviour and metabolic capacity of cryopreserved human primary hepatocytes cultivated in a perfused multiwell device. Xenobiotica. 2015;45:29-44 pubmed publisher

Yang S, Qiu Z, Zhang Q, Chen J, Chen X. Inhibitory effects of calf thymus DNA on metabolism activity of CYP450 enzyme in human liver microsomes. Drug Metab Pharmacokinet. 2014;29:475-81 pubmed publisher

Lin D, Li C, Peng Y, Gao H, Zheng J. Cytochrome p450-mediated metabolic activation of diosbulbin B. Drug Metab Dispos. 2014;42:1727-36 pubmed publisher

Wang Q, Feng J, Han H, Zhu P, Wu H, Marina M, et al. Enantioseparation of N-derivatized amino acids by micro-liquid chromatography using carbamoylated quinidine functionalized monolithic stationary phase. J Chromatogr A. 2014;1363:207-15 pubmed publisher

Fujii S, Setoguchi C, Kawazu K, Hosoya K. Impact of P-glycoprotein on blood-retinal barrier permeability: comparison of blood-aqueous humor and blood-brain barrier using mdr1a knockout rats. Invest Ophthalmol Vis Sci. 2014;55:4650-8 pubmed publisher

Tam T, Liu R, Saleem A, Arnason J, Krantis A, Haddad P, et al. The effect of Cree traditional medicinal teas on the activity of human cytochrome P450-mediated metabolism. J Ethnopharmacol. 2014;155:841-6 pubmed publisher

Glaeser H, Bujok K, Schmidt I, Fromm M, Mandery K. Organic anion transporting polypeptides and organic cation transporter 1 contribute to the cellular uptake of the flavonoid quercetin. Naunyn Schmiedebergs Arch Pharmacol. 2014;387:883-91 pubmed publisher

Uchida Y, Wakayama K, Ohtsuki S, Chiba M, Ohe T, Ishii Y, et al. Blood-brain barrier pharmacoproteomics-based reconstruction of the in vivo brain distribution of P-glycoprotein substrates in cynomolgus monkeys. J Pharmacol Exp Ther. 2014;350:578-88 pubmed publisher

Zhu L, Liu X, Zhu L, Zhang X, Fu X, Huang J, et al. Identification of human cytochrome P450 isozymes involved in the metabolism of naftopidil enantiomers in vitro. J Pharm Pharmacol. 2014;66:1534-51 pubmed publisher

Eyer K, Herger M, Krämer S, Dittrich P. Cell-free microfluidic determination of P-glycoprotein interactions with substrates and inhibitors. Pharm Res. 2014;31:3415-25 pubmed publisher

Kervezee L, Hartman R, van den Berg D, Shimizu S, Emoto Yamamoto Y, Meijer J, et al. Diurnal variation in P-glycoprotein-mediated transport and cerebrospinal fluid turnover in the brain. AAPS J. 2014;16:1029-37 pubmed publisher

Spaggiari D, Geiser L, Daali Y, Rudaz S. Phenotyping of CYP450 in human liver microsomes using the cocktail approach. Anal Bioanal Chem. 2014;406:4875-87 pubmed publisher

Wojcikowski J, Basińska A, Daniel W. The cytochrome P450-catalyzed metabolism of levomepromazine: a phenothiazine neuroleptic with a wide spectrum of clinical application. Biochem Pharmacol. 2014;90:188-95 pubmed publisher

Yuan L, Jia P, Sun Y, Zhao C, Zhi X, Sheng N, et al. Study of in vitro metabolism of m-nisoldipine in human liver microsomes and recombinant cytochrome P450 enzymes by liquid chromatography-mass spectrometry. J Pharm Biomed Anal. 2014;97:65-71 pubmed publisher

Nagaya Y, Nozaki Y, Kobayashi K, Takenaka O, Nakatani Y, Kusano K, et al. Utility of cerebrospinal fluid drug concentration as a surrogate for unbound brain concentration in nonhuman primates. Drug Metab Pharmacokinet. 2014;29:419-26 pubmed

Li L, Tu M, Yang X, Sun S, Wu X, Zhou H, et al. The contribution of human OCT1, OCT3, and CYP3A4 to nitidine chloride-induced hepatocellular toxicity. Drug Metab Dispos. 2014;42:1227-34 pubmed publisher

Lawrence S, Nguyen D, Bowen C, Richards Peterson L, Skordos K. The metabolic drug-drug interaction profile of Dabrafenib: in vitro investigations and quantitative extrapolation of the P450-mediated DDI risk. Drug Metab Dispos. 2014;42:1180-90 pubmed publisher

Zhang X, Zhang J, Li W, Liu L, Sun B, Guo Z, et al. In vitro metabolism of 20(R)-25-methoxyl-dammarane-3, 12, 20-triol from Panax notoginseng in human, monkey, dog, rat, and mouse liver microsomes. PLoS ONE. 2014;9:e94962 pubmed publisher

Wang Z, Sun J, Howell C, Zhou Q, He Z, Yang T, et al. Prediction of the likelihood of drug interactions with kinase inhibitors based on in vitro and computational studies. Fundam Clin Pharmacol. 2014;28:551-82 pubmed publisher

Kim T, Lee H, Lim K, Lee S, Yoon S, Park K, et al. Effects of HM30181, a P-glycoprotein inhibitor, on the pharmacokinetics and pharmacodynamics of loperamide in healthy volunteers. Br J Clin Pharmacol. 2014;78:556-64 pubmed publisher

Milligan C, Li M, Gazina E, Heron S, Nair U, Trager C, et al. KCNT1 gain of function in 2 epilepsy phenotypes is reversed by quinidine. Ann Neurol. 2014;75:581-90 pubmed publisher

Ericsson T, Sundell J, Torkelsson A, Hoffmann K, Ashton M. Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies. Xenobiotica. 2014;44:615-26 pubmed publisher

Boulé S, Kouakam C, Brigadeau F. Very prolonged episode of self-terminating ventricular fibrillation in a patient with Brugada syndrome. Can J Cardiol. 2013;29:1742.e1-3 pubmed publisher

Stahl S. Mechanism of action of dextromethorphan/quinidine:comparison with ketamine. CNS Spectr. 2013;18:225-7 pubmed

Ishiyama T, Urabe D, Fujisawa H, Inoue M. Concise synthesis of the multiply oxygenated ABC-ring system of the dihydro-?-agarofurans. Org Lett. 2013;15:4488-91 pubmed publisher

Jin X, Pybus B, Marcsisin R, Logan T, Luong T, Sousa J, et al. An LC-MS based study of the metabolic profile of primaquine, an 8-aminoquinoline antiparasitic drug, with an in vitro primary human hepatocyte culture model. Eur J Drug Metab Pharmacokinet. 2014;39:139-46 pubmed

Murakami Y, Shimizu Y, Ogasawara A, Ueshima S, Nakayama M, Kawata K, et al. Interspecies comparison of hepatic metabolism of six newly synthesized retinoid X receptor agonistic compounds possessing a 6-[N-ethyl-N-(alkoxyisopropylphenyl)amino]nicotinic acid skeleton in rat and human liver microsomes. Drug Dev Ind Pharm. 2014;40:1065-71 pubmed publisher

Chan G, Saldivia V, Yang Y, Pang H, de Lannoy I, Bendayan R. In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: an intracerebral microdialysis study. J Neurochem. 2013;127:342-52 pubmed publisher

Pellegrino P, Di Biase M, Brunetti N. Quinidine for the management of electrical storm in an old patient with Brugada syndrome and syncope. Acta Cardiol. 2013;68:201-3 pubmed

Obeyesekere M, Klein G, Nattel S, Leong Sit P, Gula L, Skanes A, et al. A clinical approach to early repolarization. Circulation. 2013;127:1620-9 pubmed publisher

Viskin S, Wilde A, Guevara Valdivia M, Daoulah A, Krahn A, Zipes D, et al. Quinidine, a life-saving medication for Brugada syndrome, is inaccessible in many countries. J Am Coll Cardiol. 2013;61:2383-7 pubmed publisher

Jain R, Dhanjai -. Nano graphene based sensor for antiarrhythmic agent quinidine in solubilized system. Colloids Surf B Biointerfaces. 2013;105:278-83 pubmed publisher

Martinkova M, Kubickova B, Stiborova M. Effects of cytochrome P450 inhibitors on peroxidase activity. Neuro Endocrinol Lett. 2012;33 Suppl 3:33-40 pubmed

Guo Q, Zhao J. Highly enantioselective three-component direct Mannich reactions of unfunctionalized ketones catalyzed by bifunctional organocatalysts. Org Lett. 2013;15:508-11 pubmed publisher

Ehret G, Daali Y, Chabert J, Rebsamen M, Wolff A, Forster A, et al. Influence of CYP2D6 activity on pre-emptive analgesia by the N-methyl-D-aspartate antagonist dextromethorphan in a randomized controlled trial of acute pain. Pain Physician. 2013;16:45-56 pubmed

Cassani C, Martín Rapún R, Arceo E, Bravo F, Melchiorre P. Synthesis of 9-amino(9-deoxy)epi cinchona alkaloids, general chiral organocatalysts for the stereoselective functionalization of carbonyl compounds. Nat Protoc. 2013;8:325-44 pubmed publisher

El Harchi A, Melgari D, Zhang Y, Zhang H, Hancox J. Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel. PLoS ONE. 2012;7:e52451 pubmed publisher

Lai P, Walters J. Azithromycin kills invasive Aggregatibacter actinomycetemcomitans in gingival epithelial cells. Antimicrob Agents Chemother. 2013;57:1347-51 pubmed publisher

Patel M, Dalvi P, Gokulgandhi M, Kesh S, Kohli T, Pal D, et al. Functional characterization and molecular expression of large neutral amino acid transporter (LAT1) in human prostate cancer cells. Int J Pharm. 2013;443:245-53 pubmed publisher

Kessler S, Vlimant M, Guerin P. The sugar meal of the African malaria mosquito Anopheles gambiae and how deterrent compounds interfere with it: a behavioural and neurophysiological study. J Exp Biol. 2013;216:1292-306 pubmed publisher

Bajpai P, Sangar M, Singh S, Tang W, Bansal S, Chowdhury G, et al. Metabolism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondrion-targeted cytochrome P450 2D6: implications in Parkinson disease. J Biol Chem. 2013;288:4436-51 pubmed publisher

Yang T, Smith J, Leake B, Sanders C, Meiler J, Roden D. An allosteric mechanism for drug block of the human cardiac potassium channel KCNQ1. Mol Pharmacol. 2013;83:481-9 pubmed publisher

Ishii K, Norota I, Obara Y. Endocytic regulation of voltage-dependent potassium channels in the heart. J Pharmacol Sci. 2012;120:264-9 pubmed

Sequiera G, Mehta A, Ooi T, Shim W. Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart. Life Sci. 2013;92:63-71 pubmed publisher

Pandey S, Dwivedi H, Singh S, Siddiqui W, Tripathi R. Antimalarial interaction of quinine and quinidine with clarithromycin. Parasitology. 2013;140:406-13 pubmed publisher

Barot M, Gokulgandhi M, Pal D, Mitra A. Mitochondrial localization of P-glycoprotein and peptide transporters in corneal epithelial cells--novel strategies for intracellular drug targeting. Exp Eye Res. 2013;106:47-54 pubmed publisher

Gorka A, Sherlach K, De Dios A, Roepe P. Relative to quinine and quinidine, their 9-epimers exhibit decreased cytostatic activity and altered heme binding but similar cytocidal activity versus Plasmodium falciparum. Antimicrob Agents Chemother. 2013;57:365-74 pubmed publisher

Wu S, Zeng W, Wang Q, Chen F. Asymmetric trifluoromethylation of aromatic aldehydes by cooperative catalysis with (IPr)CuF and quinidine-derived quaternary ammonium salt. Org Biomol Chem. 2012;10:9334-7 pubmed publisher

Cros C, Skinner M, Moors J, Lainee P, Valentin J. Detecting drug-induced prolongation of the QRS complex: new insights for cardiac safety assessment. Toxicol Appl Pharmacol. 2012;265:200-8 pubmed publisher

Belhassen B. Is quinidine the ideal drug for brugada syndrome?. Heart Rhythm. 2012;9:2001-2 pubmed publisher

Bett G, Lis A, Guo H, Liu M, Zhou Q, Rasmusson R. Interaction of the S6 proline hinge with N-type and C-type inactivation in Kv1.4 channels. Biophys J. 2012;103:1440-50 pubmed publisher

Kallem R, Kulkarni C, Patel D, Thakur M, Sinz M, Singh S, et al. A simplified protocol employing elacridar in rodents: a screening model in drug discovery to assess P-gp mediated efflux at the blood brain barrier. Drug Metab Lett. 2012;6:134-44 pubmed

Marquez M, Bonny A, Hernández Castillo E, De Sisti A, Gómez Flores J, Nava S, et al. Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review. Heart Rhythm. 2012;9:1995-2000 pubmed publisher

Phillips K, Hirsch G, Epstein D, Preston K. Cardiac complications of unwitting co-injection of quinine/quinidine with heroin in an intravenous drug user. J Gen Intern Med. 2012;27:1722-5 pubmed publisher

Garnock Jones K. Dextromethorphan/quinidine: in pseudobulbar affect. CNS Drugs. 2011;25:435-45 pubmed publisher

Olney N, Rosen H. AVP-923, a combination of dextromethorphan hydrobromide and quinidine sulfate for the treatment of pseudobulbar affect and neuropathic pain. IDrugs. 2010;13:254-65 pubmed

Yang F, Hanon S, Lam P, Schweitzer P. Quinidine revisited. Am J Med. 2009;122:317-21 pubmed publisher

Rosen H. Dextromethorphan/quinidine sulfate for pseudobulbar affect. Drugs Today (Barc). 2008;44:661-8 pubmed publisher

Kaufman E. Quinidine in short QT syndrome: an old drug for a new disease. J Cardiovasc Electrophysiol. 2007;18:665-6 pubmed

Smith R. Dextromethorphan/quinidine: a novel dextromethorphan product for the treatment of emotional lability. Expert Opin Pharmacother. 2006;7:2581-98 pubmed

Huston M, Levinson M. Are one or two dangerous? Quinine and quinidine exposure in toddlers. J Emerg Med. 2006;31:395-401 pubmed

. Dextromethorphan/quinidine: AVP 923, dextromethorphan/cytochrome P450-2D6 inhibitor, quinidine/dextromethorphan. Drugs R D. 2005;6:174-7 pubmed

Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation. 2004;110:1731-7 pubmed

Procop G, Jessen R, Hyde S, Scheck D. Persistence of Plasmodium falciparum in the placenta after apparently effective quinidine/clindamycin therapy. J Perinatol. 2001;21:128-30 pubmed

Wijnberg I, van der Kolk J. [Regulation of atrial fibrillation in horses with oral quinidine sulfate. Discussion of the disease picture in a typical case]. Tijdschr Diergeneeskd. 2000;125:449-52 pubmed

Pianka P, Lazar M, Geyer O. [Topical optical beta-adrenergic antagonists and quinidine--a risky combination]. Harefuah. 1998;134:402-3 pubmed

Humphries J. Unexpected instant death following successful coronary artery bypass graft surgery (and other clinical settings): atrial fibrillation, quinidine, procainamide, et cetera, and instant death. Clin Cardiol. 1998;21:711-8 pubmed

Grace A, Camm A. Quinidine. N Engl J Med. 1998;338:35-45 pubmed

Brembilla Perrot B, Beurrier D, Jacquemin L, Malak S, Danchin N. [Quinidine and high-amplification ECG]. Ann Cardiol Angeiol (Paris). 1997;46:15-20 pubmed

Olshansky B. Dofetilide versus quinidine for atrial flutter: viva la difference!?. J Cardiovasc Electrophysiol. 1996;7:828-32 pubmed

Higginbotham E. Topical beta-adrenergic antagonists and quinidine. A risky interaction. Arch Ophthalmol. 1996;114:745-6 pubmed

Alloway J, Salata M. Quinidine-induced rheumatic syndromes. Semin Arthritis Rheum. 1995;24:315-22 pubmed